FBT Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | US Equities - Industry Sector | Expense | 0.55% | Return% 1Y | 43.8% | Total Holdings | 31 | Perf Week | 2.14% | Volume | 60,260 |
| Asset Type | Equities (Stocks) | AUM | $3.01B | Return% 3Y | 23.58% | NAV | $272.54 | Perf Month | -1.48% | Avg Volume | 0.08M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | 10.74% | 52W High | -2.17% | Perf Quarter | 9.12% | Rel Volume | 0.76 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | 11.65% | 52W Low | 44.6% | Perf Half Y | 31.96% | Prev Close | $272.68 |
| IPO | 2006/6/23 | Flows% 1M | 1.33% | Return% SI | 13.83% | RSI (14) | 52.51 | Perf YTD | 30.37% | Price | $269.25 |
| Beta | 0.68 | Flows% 3M | -2.31% | Flows% YTD | 49.89% | Flows% 1Y | 56.24% | Perf Year | 42.19% | Volatility(W/M) | 1.36% 1.77% |
| SMA20 | 0.74% | SMA50 | 0.57% | SMA200 | 16.35% | ATR | 4.89 | ||||
First Trust NYSE Arca Biotechnology Index Fund seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
The top 10 make up 43% of the fund
CORT CORCEPT THERAPEUTICS INC 5.60% 2 
NEO NEOGENOMICS INC 5.12% 3 
VCYT VERACYTE INC 5.10% 4 
BRKR BRUKER CORP 4.32% 5 
ALKS ALKERMES PLC 4.24% 6 
ILMN ILLUMINA INC 3.92% 7 
KRYS KRYSTAL BIOTECH INC 3.87% 8 
NTRA NATERA INC 3.79% 9 
AXSM AXSOME THERAPEUTICS INC 3.71% 10 
NBIX NEUROCRINE BIOSCIENCES INC 3.53% Largest sectors first.
Over the past 1 year, on the higher side
2% below its 1-year high.
Traded less than usual. That is 76% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +64.1%. The S&P 500 did +68% over the same period.
Tap to view numbers
The price swings a lot
At its worst (February 2021) it fell 32% and took 961 days to recover.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Money keeps flowing in
Over the past year, new money equal to 56.2% of assets came in.
Tap to view numbers
LABU Direxion Daily S&P Biotech Bull 3X ETF 612M 
MRNY YieldMax MRNA Option Income Strategy ETF 213M 
BIB ProShares Ultra Nasdaq Biotechnology 2X Shares 97M 
LABD-1× Direxion Daily S&P Biotech Bear 3X ETF 77M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
VFH Vanguard Financials ETF 0.09% 
ONEQ Fidelity Nasdaq Composite Index ETF 0.21% 
VIS Vanguard Industrials ETF 0.09% 
FV First Trust Dorsey Wright Focus 5 ETF 0.89% 
IYF iShares U.S. Financials ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
